The mean 9.4% BW reduction exhibited by patients treated with OW semaglutide 2.4 mg might partially explain the HF benefit observed in this trial 84 , as previously demonstrated for treatments leading to at least 10% weight loss 87
DOBLE ACCION
The body already possesses an extraordinarily sophisticated metabolic control system one that evolved in response to whole foods, complex fibres and a diverse gut microbiome
In 2025, Hims jumped on the GLP-1 craze, partnering with Novo Nordisk for compounded semaglutide, a Wegovy knockoff, amid shortages
The 2024-2025 period saw the FDA move both compounds off the shortage list, which closed the compounding-pharmacy door for branded-equivalent formulations
Develop a personalized plan that includes GLP-1 medications, nutritional counseling, and video lifestyle coaching to support your journey